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The authors have advised due to an error that occurred inadvertently at the time of figure assembly, [Figure 2M](#F0001){ref-type="fig"} on page 3956 is incorrect.

The correct [Figure 2](#F0001){ref-type="fig"} is shown below.

The authors have also advised there is an error in [Figure 3](#F0001){ref-type="fig"} on page 3960. The concentration units in part B show "mg" they should read "mg/ml".

The correct [Figure 3](#F0001){ref-type="fig"} is shown below.

The authors apologize for these errors.

![LIP3 bimodal imagining in vitro. (**A**) LIP3 CEUS imaging and grey value histogram of different groups in vitro. (**B**) LIP3 PA imaging and PA value scatter diagram with different concentrations in vitro.](IJN-15-6089-g0001){#F0001}
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![General physicochemical properties of LIP3. (**A**) Structure illustration of LIP0, LIP1, LIP2, and LIP3. (**B**) TEM of LIP3. (**C**) Phasing sign TEM of LIP3. (**D**) Light microscopy image of LIP3. (**E**) Fluorescence microscope image of DiI-stained LIP3 NPs (×400). (**F**) Zeta potential of LIP1, LIP2, and LIP3. (**G**) Size of LIP1, LIP2, and LIP3. (**H**) LIP3 light microscopy image of the sonogenic phase transition (× 400). (**I**) Correlation between concentration of AQ4N and absorbance. (**J**) Correlation between concentration of HMME and absorbance. (**K**) UV-vis--NIR absorbance spectra of LIP1, LIP2, and LIP3 and free HMME, AQ4N. (**L**) Relative production of active oxygen of LIP3. (**M**) LIP3 size distribution with prolonged time duration. Insert: digital photos of the LIP3 NPs dispersed in PBS (2.5 mg/mL).](IJN-15-6089-g0003){#F0002b}
